Whiting Samuel has filed 5 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 270000 shares of Tempest Therapeutics, Inc. ($TPST) on January 02, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2025 | Tempest Therapeutics, Inc. | $TPST | Whiting Samuel | Chief Medical Officer | A | Employee Stock Option (right to buy) | 270000 | $0.00 | 270,000.0000 | 0 | 9999.99% | 0.00% |
| July 2, 2024 | Tempest Therapeutics, Inc. | $TPST | Whiting Samuel | Chief Medical Officer | P | Common Stock | 4672 | $2.13 | 9,573.0000 | 0 | 95.33% | 0.00% |
| Jan. 3, 2024 | Tempest Therapeutics, Inc. | $TPST | Whiting Samuel | Chief Medical Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2023 | Tempest Therapeutics, Inc. | $TPST | Whiting Samuel | Chief Medical Officer | A | Employee Stock Option (right to buy) | 325000 | $0.00 | 325,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2023 | Tempest Therapeutics, Inc. | $TPST | Whiting Samuel | Chief Medical Officer | A | Employee Stock Option (right to buy) | 69700 | $0.00 | 69,700.0000 | 0 | 9999.99% | 0.00% |